Special Collections

Clinician POV

Asthma in children has become more prevalent over the last several decades. Treatment options for addressing treatment-resistant, allergic-type severe asthma have advanced in recent years, as research has begun to uncover the pathological processes that underlie asthma phenotypes. In this article, Meyer Kattan, MD, professor of pediatrics at Columbia University and director of the Pediatric Pulmonary Division at New York-Presbyterian/Morgan Stanley Children’s Hospital, discusses state-of-the-art treatments for severe allergic asthma in children and future directions for research.

While naloxone, a short-acting opioid antagonist, has become the standard treatment for opioid overdose, there are situations where longer-acting opioid antagonists are a more appropriate treatment choice, especially considering the rise of fentanyl. In this article, Dr Adam Bisaga, professor of psychiatry at the Columbia University Irving Medical Center in New York and research scientist at the New York State Psychiatric Institute, discusses various clinical considerations in the treatment of opioid overdose and opioid use disorder.

Phyllis Tien, MD, a professor of medicine in the Division of Infectious Diseases at the University of California, San Francisco, and a staff physician at the San Francisco Veterans Affairs Health Care System, discusses the effectiveness of the COVID-19 bivalent booster vaccine in preventing serious infection.